Leadership


Michael A. Caligiuri, MD
Director of The Ohio State University Comprehensive Cancer Center CEO of the James Cancer Hospital and Solove Research Institute

Clara D. Bloomfield, MD
Distinguished University Professor
Cancer Scholar and Senior Advisor

Jeff Walker, MBA
Senior Executive Director for Administration

Peter Shields, MD
Deputy Director, The Ohio State University Comprehensive Cancer Center

Richard Goldberg, MD
Physician-in-Chief, the James Cancer Hospital and Solove Research Institute

Executive Cabinet

Julian Bell, MHA, CPA
Chief Financial Officer

Stacey Bennet, JD
Assistant General Counsel of Legal Affairs

Charley Borden, MBA
Associate Executive Director, Quality and Patient Safety

Jennifer Carlson
Assistant Vice President of Government Affairs

Steve Chaykowski
Executive Director, Development

Melissa Childress, MBA
Associate Executive Director, Business Development

Mark Conselyea, MHA
Associate Executive Director, Facilities and Space

Melissa Hall
Interim Chief Communications Officer

Jill Hannah, MLHR
Director, Human Resources

Kris M. Kipp, MSN, RN
Chief Nursing Officer

Chris Scarcello, MBA
Director of Research Administration

Nancy Single, PhD
Director of Clinical Research Operations

R. Michael Townsend, PhD
Chief Information Officer

Timothy R. Wright
Director, Drug Development

Contact The James

General Inquiries

800-293-5066

Email

Address

460 W. 10th Avenue
Columbus, OH 43210


Get Your Medical Records

614-293-8657


Get Your Medical Bills

614-293-2100

Online Bill Pay


Give Us Feedback

Latest News

Nobel Prize Winner Carol Greider to Present Annual Block Lecture at Ohio State

Carol Greider, PhD, recipient of the 2009 Nobel Prize in Physiology or Medicine, will receive the 21st annual Herbert and Maxine Block Memorial Lectureship Award for Achievement in Cancer. The Block...

Read More

Researchers Detail Reasons for Ibrutinib Therapy Discontinuation in Chronic Lymphocytic Leukemia

About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical...

Read More

Exciting Research in Lung Cancer Diagnosis and Treatments

This week on Toward a Cancer-Free World, we see how lung cancer treatments are now changing, thanks to exciting new research at The James.

Read More